Europe Mass Spectrometry and Chromatography in Diagnostics Market By Product Type (Sample Preparation, Mass Spectrometry, Chromatography), By Sample Type (Blood, Urine, Serum, Plasma, Saliva), By Application (Therapeutic Drug Monitoring, Vitamins, Hormones, Methylmalonic Acid, Immunosuppressants, Others), By Testing Type (Laboratory-Developed Tests, Commercial Assays), By Country, Competition, Forecast and Opportunities, 2020-2030F
Market Report I 2025-04-25 I 132 Pages I TechSci Research
Market Overview
The Europe Mass Spectrometry and Chromatography in Diagnostics Market was valued at USD 219.36 million in 2024 and is anticipated to reach USD 377.62 million by 2030, growing at a CAGR of 9.45%. This growth is driven by the rising demand for high-precision, reliable, and sensitive diagnostic tools in clinical environments. As personalized medicine gains traction, there is a growing need for technologies capable of early and accurate disease detection. Mass spectrometry and chromatography are pivotal in this transformation, offering multi-target analysis and high specificity for identifying biomarkers in complex biological samples. Their application spans oncology, cardiology, infectious diseases, and more, enhancing individualized treatment strategies and improving patient outcomes. Additionally, advancements in resolution, sensitivity, and automation of these technologies are expanding their diagnostic capabilities. The increased integration of LC-MS and GC-MS in therapeutic drug monitoring and biomarker discovery, along with a shift toward non-invasive diagnostics, further supports the market's expansion across Europe.
Key Market Drivers
Increasing Prevalence of Chronic Diseases
The rising burden of chronic diseases in Europe is significantly fueling the demand for mass spectrometry and chromatography in diagnostics. Conditions such as cancer, diabetes, cardiovascular diseases, and chronic kidney disease require accurate and early diagnosis, which these technologies effectively deliver through high-sensitivity biomarker detection. In 2022, Europe recorded over 4.47 million new cancer cases, with a cumulative risk of nearly 28% by age 75. The region also saw approximately 1.1 million deaths related to diabetes in 2021 among adults aged 20-79. Such figures underscore the critical need for advanced diagnostic tools. Mass spectrometry and chromatography offer detailed molecular insights essential for diagnosis, prognosis, and treatment personalization. Their ability to support early disease identification is transforming chronic disease management and directly contributing to the growth of the diagnostic market in Europe.
Key Market Challenges
High Initial Investment Costs
High initial investment costs pose a considerable obstacle to broader adoption of mass spectrometry and chromatography technologies in diagnostic applications across Europe. These advanced instruments require significant capital, with expenses often reaching hundreds of thousands of euros per system. This financial barrier is especially challenging for small- and mid-sized diagnostic laboratories and healthcare facilities with limited budgets. In addition to equipment costs, setup expenses include infrastructure upgrades such as climate-controlled labs, safety systems, and reliable power supplies. The high costs also encompass personnel training and system maintenance, further complicating adoption. As a result, the market growth is constrained in regions where funding or reimbursement policies cannot support such investments.
Key Market Trends
Miniaturization of Mass Spectrometry Instruments
Miniaturization is a major trend reshaping the Europe Mass Spectrometry and Chromatography in Diagnostics Market. Compact mass spectrometry instruments are being engineered for point-of-care and decentralized diagnostic settings, offering portability without compromising analytical performance. These systems are especially valuable in emergency rooms, outpatient clinics, and remote healthcare environments, where faster diagnostics are essential. Miniaturized mass spectrometers, enhanced by microfluidic components and ambient ionization, reduce the need for extensive sample preparation and enable near-instant results. They also feature user-friendly interfaces and wireless connectivity, making them accessible to non-specialist users and compatible with telemedicine platforms. As these innovations become regulatory-approved, their adoption is expected to rise, supporting a shift toward patient-centric, decentralized diagnostics that offer rapid and accurate results.
Key Market Players
- Merck KGaA
- Thermo Fisher Scientific
- Tecan Trading AG
- Gerstel GmbH & Co. KG
- Chromsystems Instruments & Chemicals GmbH
- RECIPE Chemicals + Instruments GmbH
- SENTINEL CH. SpA
- Siemens Healthineers AG
- Waters S.A.S.
- Shimadzu Europa GmbH
Report Scope:
In this report, the Europe Mass Spectrometry and Chromatography in Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Europe Mass Spectrometry and Chromatography in Diagnostics Market, By Product Type:
o Sample Preparation
o Mass Spectrometry
o Chromatography
- Europe Mass Spectrometry and Chromatography in Diagnostics Market, By Sample Type:
o Blood
o Urine
o Serum
o Plasma
o Saliva
- Europe Mass Spectrometry and Chromatography in Diagnostics Market, By Application:
o Therapeutic Drug Monitoring
o Vitamins
o Hormones
o Methylmalonic Acid
o Immunosuppressants
o Others
- Europe Mass Spectrometry and Chromatography in Diagnostics Market, By Testing Type:
o Laboratory-Developed Tests
o Commercial Assays
- Europe Mass Spectrometry and Chromatography in Diagnostics Market, By Country:
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Poland
o Bulgaria
o Finland
o Portugal
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Europe Mass Spectrometry and Chromatography in Diagnostics Market.
Available Customizations:
Europe Mass Spectrometry and Chromatography in Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Europe Mass Spectrometry and Chromatography in Diagnostics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Sample Preparation, Mass Spectrometry, Chromatography)
5.2.2. By Sample Type (Blood, Urine, Serum, Plasma, Saliva)
5.2.3. By Application (Therapeutic Drug Monitoring, Vitamins, Hormones, Methylmalonic Acid, Immunosuppressants, Others)
5.2.4. By Testing Type (Laboratory-Developed Tests, Commercial Assays)
5.2.5. By Country
5.2.6. By Company (2024)
5.3. Market Map
6. Europe: Country Analysis
6.1. Germany Mass Spectrometry and Chromatography in Diagnostics Market Outlook
6.1.1. Market Size & Forecast
6.1.1.1. By Value
6.1.2. Market Share & Forecast
6.1.2.1. By Product Type
6.1.2.2. By Sample Type
6.1.2.3. By Application
6.1.2.4. By Testing Type
6.2. France Mass Spectrometry and Chromatography in Diagnostics Market Outlook
6.2.1. Market Size & Forecast
6.2.1.1. By Value
6.2.2. Market Share & Forecast
6.2.2.1. By Product Type
6.2.2.2. By Sample Type
6.2.2.3. By Application
6.2.2.4. By Testing Type
6.3. United Kingdom Mass Spectrometry and Chromatography in Diagnostics Market Outlook
6.3.1. Market Size & Forecast
6.3.1.1. By Value
6.3.2. Market Share & Forecast
6.3.2.1. By Product Type
6.3.2.2. By Sample Type
6.3.2.3. By Application
6.3.2.4. By Testing Type
6.4. Italy Mass Spectrometry and Chromatography in Diagnostics Market Outlook
6.4.1. Market Size & Forecast
6.4.1.1. By Value
6.4.2. Market Share & Forecast
6.4.2.1. By Product Type
6.4.2.2. By Sample Type
6.4.2.3. By Application
6.4.2.4. By Testing Type
6.5. Spain Mass Spectrometry and Chromatography in Diagnostics Market Outlook
6.5.1. Market Size & Forecast
6.5.1.1. By Value
6.5.2. Market Share & Forecast
6.5.2.1. By Product Type
6.5.2.2. By Sample Type
6.5.2.3. By Application
6.5.2.4. By Testing Type
6.6. Russia Mass Spectrometry and Chromatography in Diagnostics Market Outlook
6.6.1. Market Size & Forecast
6.6.1.1. By Value
6.6.2. Market Share & Forecast
6.6.2.1. By Product Type
6.6.2.2. By Sample Type
6.6.2.3. By Application
6.6.2.4. By Testing Type
6.7. Poland Mass Spectrometry and Chromatography in Diagnostics Market Outlook
6.7.1. Market Size & Forecast
6.7.1.1. By Value
6.7.2. Market Share & Forecast
6.7.2.1. By Product Type
6.7.2.2. By Sample Type
6.7.2.3. By Application
6.7.2.4. By Testing Type
6.8. Bulgaria Mass Spectrometry and Chromatography in Diagnostics Market Outlook
6.8.1. Market Size & Forecast
6.8.1.1. By Value
6.8.2. Market Share & Forecast
6.8.2.1. By Product Type
6.8.2.2. By Sample Type
6.8.2.3. By Application
6.8.2.4. By Testing Type
6.9. Finland Mass Spectrometry and Chromatography in Diagnostics Market Outlook
6.9.1. Market Size & Forecast
6.9.1.1. By Value
6.9.2. Market Share & Forecast
6.9.2.1. By Product Type
6.9.2.2. By Sample Type
6.9.2.3. By Application
6.9.2.4. By Testing Type
6.10. Portugal Mass Spectrometry and Chromatography in Diagnostics Market Outlook
6.10.1. Market Size & Forecast
6.10.1.1. By Value
6.10.2. Market Share & Forecast
6.10.2.1. By Product Type
6.10.2.2. By Sample Type
6.10.2.3. By Application
6.10.2.4. By Testing Type
7. Market Dynamics
7.1. Drivers
7.2. Challenges
8. Market Trends & Developments
8.1. Merger & Acquisition (If Any)
8.2. Product Launches (If Any)
8.3. Recent Developments
9. Europe Mass Spectrometry and Chromatography in Diagnostics Market: SWOT Analysis
10. Porters Five Forces Analysis
10.1. Competition in the Industry
10.2. Potential of New Entrants
10.3. Power of Suppliers
10.4. Power of Customers
10.5. Threat of Substitute Products
11. Competitive Landscape
11.1. Merck KGaA
11.1.1. Business Overview
11.1.2. Company Snapshot
11.1.3. Products & Services
11.1.4. Financials (As Reported)
11.1.5. Recent Developments
11.1.6. Key Personnel Details
11.1.7. SWOT Analysis
11.2. Thermo Fisher Scientific
11.3. Tecan Trading AG
11.4. Gerstel GmbH & Co. KG
11.5. Chromsystems Instruments & Chemicals GmbH
11.6. RECIPE Chemicals + Instruments GmbH
11.7. SENTINEL CH. SpA
11.8. Siemens Healthineers AG
11.9. Waters S.A.S.
11.10. Shimadzu Europa GmbH
12. Strategic Recommendations
13. About Us & Disclaimer
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.